Bone drugs for prostate cancer may result in survival benefitAugust 4, 2021Genitourinary CancerCancerOncology
Diabetes drug’s new weight-loss indication fuels cost-benefit debateAugust 3, 2021ObesityDiabetesBusiness of Medicine
Resistant TB: Adjustments to BPaL regimen reduce AEs, not efficacyJuly 19, 2021Infectious DiseasesPulmonology
Assessment of a Medication Deprescribing Tool on Polypharmacy and Cost AvoidanceJuly 12, 2021Mixed Topics
Heart failure med undertreatment because of older age common, flouts evidenceJuly 7, 2021CardiologyGeriatrics
